Veeva Extends Remote Meeting Capabilities to Zoom and Microsoft Teams
Veeva Systems (NYSE: VEEV) today announced it is bringing Veeva CRM Engage Meeting functionality to Zoom and Microsoft Teams. Now customers will have greater flexibility and choice in how they conduct remote meetings and connect with healthcare professionals (HCPs).
“Our open approach gives the life sciences industry the freedom to use Veeva software the way that works best for them and meets their needs,” said Arno Sosna, general manager of Veeva CRM . “Customers will have more options in how they leverage Veeva CRM Engage Meeting and collaborate with doctors that may already be using Zoom and Microsoft Teams.”
Seamless integration with Zoom and Microsoft Teams enables customers to benefit from the same innovative functionality in Veeva CRM Engage Meeting across any platform. Companies can use remote sampling to capture HCP product sample requests; remote medical inquiry management to compliantly respond to HCP medical inquiries; and remote consent for HCPs to approve their communication preferences remotely.
Veeva CRM Engage Meeting makes online meetings with healthcare providers easy and compliant. The application is free for life sciences companies through December 2020 so they can stay connected with HCPs as in-person access remains limited during COVID-19. Integration with Zoom and Microsoft Teams is planned for availability in January 2021.
In other news today, Veeva announced that Syneos Health is offering biopharmaceutical customers Veeva Commercial Cloud solutions to speed commercial launches. Read today’s press release for more information.
To learn more about Veeva CRM Engage Meeting, visit: veeva.com/EngageMeeting .
About Veeva Systems
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 875 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com/eu .
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended April 30, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov . Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
® 2020 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc.
Veeva Systems Inc. owns other registered and unregistered trademarks.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ARGO-BLOCKCHAIN18.1.2021 09:48:48 CET | Press release
Argo Blockchain PLC announces £22.4 Million Private Placement with Institutional Investors and Mining Capacity Expansion
REPLY18.1.2021 09:32:47 CET | Press release
Reply Signs an Agreement with AWS to Develop Industry Solutions
L&T-TECHNOLOGY-SERVICES18.1.2021 09:02:44 CET | Press release
L&T Technology Services Rated as Global Pure-Play ER&D Services Leader by Zinnov
CA-GUARDANT-HEALTH18.1.2021 09:02:44 CET | Press release
Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe
NJ-TOPCON-HEALTHCARE18.1.2021 07:02:46 CET | Press release
Topcon Announces eyeRISE 2021 Virtual Symposia & Expo
SERVIER16.1.2021 22:17:39 CET | Press release
Servier announce updated overall survival results of exploratory TASCO1 phase II study of LONSURF® + bevacizumab in a first-line setting for patients with unresectable mCRC non-eligible for intensive therapy
CA-ANDERSEN-GLOBAL15.1.2021 11:01:39 CET | Pressemeddelelse
Andersen Global træder ind i Sverige i samarbejde med Unum Tax
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom